Genmab
Genmab

How Insourcing Transformed Antibody Manufacturing Success!
BIOT
🚀 Insourcing cell-line development has transformed antibody manufacturing for Genmab, enhancing efficiency and boosting production quality. 🌟💉 Biotech Innovation

Genmab’s $18bn Acquisition Boosts Cancer Pipeline
BIOT
💥 Genmab is acquiring ProfoundBio for $1.8bn to expand its pipeline of antibody-drug conjugate therapies. 💊🏭🚀


